Adient has spent the past year raising its sales forecast and getting little credit for it. Management has lifted its fiscal 2026 revenue outlook four times, from roughly $14.4 billion to about $15.0 billion, yet adjusted EBITDA guidance has sat near $885 million for three straight quarters. That gap between a rising top line and a stalled profit line is the story heading into the September-quarter report on November 4. With shares down sharply since the last update, the market seems to doubt that extra volume will ever turn into extra earnings.
Wall Street expects earnings of $0.63 per share on revenue of about $3.59 billion. That would be a 21% gain in EPS from $0.52 a year ago, even as revenue slips about 2.7%. In other words, the Street is betting on margin improvement rather than growth. The whisper number of $0.61 sits a touch below consensus. The gap is small, but it points to some caution about profitability rather than any appetite for a big upside surprise. Consensus for the full year also still sits around $14.8 billion, below management's raised $15.0 billion target. That leaves room for a revenue beat if the company delivers on its own forecast.
The margin question comes down to costs that management called temporary. Third-quarter EBITDA of $225M was flat year over year and margin was just 5.7%. Roughly $32 million of drag weighed on results: about $20 million tied to Middle East freight, commodity and resin costs, plus about $12 million of customer-driven inefficiencies, notably around full-size pickup schedules. Management said margin would have been in the mid-6% range without those items. It also said recoveries on the Middle East costs lag about two quarters, with some landing in the fourth quarter. That makes this report the first real test of the claim. If those recoveries show up and pickup schedules settle, the EPS growth the Street expects looks achievable. If the cost estimate rises again, the temporary label loses credibility. It already climbed from a $25 million second-half figure to $35 to $40 million for the full year.
Cash flow needs careful reading. Adient generated $161 million of free cash flow through three quarters, but a roughly $45 million customer payment timing benefit is set to reverse. Its full-year target of about $130 million implies a negative fourth quarter. A weak cash number would therefore not be a surprise in itself. What matters is whether the company lands on or above that target, which would support continued buybacks after a $55 million year-to-date pace and a Moody's upgrade to Ba3.
Because this closes the fiscal year, the discussion will likely lean heavily toward 2027, and that is where the bearish turn in sentiment comes in. Readings have swung from moderately bullish before the last report to modestly bearish now. The stock has fallen about 18% since the third-quarter release, trailing the S&P 500 by nearly 17 points. At $16.75 it trades well below its 200-day average of $20.65 and close to the bottom of its post-earnings range, near a $15.91 low that undercut the prior quarter's floor. Investors appear to be pricing in the risks management already flagged. Those include further China margin compression into fiscal 2027 as local automakers approach 70% of the mix, the roll-off of about $90 million of EMEA metals business, and restructuring costs that could run $30 million or more per plant closure.
On the other side are a booked backlog of about $400 million for fiscal 2027 and an estimated $500 million onshoring and conquest opportunity, including the Chevrolet Equinox win. China sales are also growing quickly. The central question is whether Adient can show that its growth engines produce more profit than its cost and mix headwinds take away. A clean quarter, with temporary costs fading and a fiscal 2027 view that holds EBITDA steady or higher, would challenge the deep skepticism in the share price. Another raise in sales with flat profit would reinforce it.